RT Journal Article
SR Electronic
T1 Talimogene laherparepvec upregulates immune-cell populations in non-injected lesions: findings from a phase II, multicenter, open-label study in patients with stage IIIB–IVM1c melanoma
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e001621
DO 10.1136/jitc-2020-001621
VO 9
IS 3
A1 Malvehy, Josep
A1 Samoylenko, Igor
A1 Schadendorf, Dirk
A1 Gutzmer, Ralf
A1 Grob, Jean-Jacques
A1 Sacco, Joseph J
A1 Gorski, Kevin S
A1 Anderson, Abraham
A1 Pickett, Cheryl A
A1 Liu, Kate
A1 Gogas, Helen
YR 2021
UL http://jitc.bmj.com/content/9/3/e001621.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.